Information Journal Paper
APA:
Copy. (2018). ACRIN 6684: multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy. PLOS ONE, 13(6), 0-0. SID. https://sid.ir/paper/737756/en
Vancouver:
Copy. ACRIN 6684: multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy. PLOS ONE[Internet]. 2018;13(6):0-0. Available from: https://sid.ir/paper/737756/en
IEEE:
Copy, “ACRIN 6684: multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy,” PLOS ONE, vol. 13, no. 6, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/737756/en